125 related articles for article (PubMed ID: 31608892)
21. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
[TBL] [Abstract][Full Text] [Related]
22. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
[TBL] [Abstract][Full Text] [Related]
23. Cardiopulmonary exercise test and PaO
Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S
Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921
[TBL] [Abstract][Full Text] [Related]
24. [The effect of chronic intermittent hypoxia caused by obstructive sleep apnea hypopnea syndrome on blood pressure].
Mo L; Gai J; He QY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):898-903. PubMed ID: 18336764
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
26. Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array.
Zhang Y; Lin P; Hong C; Jiang Q; Xing Y; Tang X; Jiang H; Luo S; Chen X
Cytokine; 2018 Nov; 111():342-349. PubMed ID: 30273784
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
28. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
de Torres JP; Cordoba-Lanus E; López-Aguilar C; Muros de Fuentes M; Montejo de Garcini A; Aguirre-Jaime A; Celli BR; Casanova C
Eur Respir J; 2006 May; 27(5):902-7. PubMed ID: 16455829
[TBL] [Abstract][Full Text] [Related]
30. Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Low A; George S; Howard L; Bell N; Millar A; Tulloh RMR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29444773
[TBL] [Abstract][Full Text] [Related]
31. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
[TBL] [Abstract][Full Text] [Related]
32. [OPTIMIZATION OF DIAGNOSIS OF PULMONARY HYPERTENSION SYNDROME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN COMBINATION WITH ISCHEMIC HEART DISEASE].
Kolesnikova O; Krakhmalova O; Trutaev S
Georgian Med News; 2018 Sep; (282):73-79. PubMed ID: 30358544
[TBL] [Abstract][Full Text] [Related]
33. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
34. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Lee TM; Chen CC; Shen HN; Chang NC
Clin Sci (Lond); 2009 Mar; 116(6):497-505. PubMed ID: 18831711
[TBL] [Abstract][Full Text] [Related]
35. Increased Plasma Level of miR-210 as a Potential Diagnostic Marker for Chronic Obstructive Pulmonary Disease Induced Pulmonary Hypertension.
Huang H; Wu F; Yang J; Li H; Cai M; Shan K; Shi S
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538057
[TBL] [Abstract][Full Text] [Related]
36. Changes of Number and Function of Late Endothelial Progenitor Cells in Peripheral Blood of COPD Patients Combined with Pulmonary Hypertension.
Liu P; Zhang H; Liu J; Sheng C; Zhang L; Zeng Y
Thorac Cardiovasc Surg; 2016 Jun; 64(4):323-9. PubMed ID: 25226359
[TBL] [Abstract][Full Text] [Related]
37. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
38. Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Bacakoğlu F; Atasever A; Ozhan MH; Gurgun C; Ozkilic H; Guzelant A
Respiration; 2003; 70(6):594-9. PubMed ID: 14732789
[TBL] [Abstract][Full Text] [Related]
39. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
40. Comparison of C-reactive protein levels in patients with lung cancer and chronic obstructive pulmonary disease.
Vagulienė N; Žemaitis M; Miliauskas S; Urbonienė D; Šitkauskienė B; Sakalauskas R
Medicina (Kaunas); 2011; 47(8):421-7. PubMed ID: 22123552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
